At the end of the day, if something as simple as appointment scheduling is enough to significantly prolong life for cancer ...

One of the world’s largest clinical studies on lung cancer—with significant Greek participation—was recently presented at the ...

Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...

Johnson & Johnson launches The 3rd Opinion in Asia Pacific: a new term to elevate the patient voice in the lung cancer ...

Second quarter 2025 revenues increased 4% to $3.68 billion versus second quarter 2024Dupixent® global net sales (recorded by Sanofi) increased 22% to $4.34 billion EYLEA HD® U.S. net sales increased ...

SINGAPORE - Media OutReach Newswire - 1 August 2025 - Today, on World Lung Cancer Day, Johnson & Johnson announced the launch ...

FRIDAY, August 1, 2025 (HealthDay News) — Men diagnosed with what are known as Grade Group one (GG1) prostate tumors are ...

Women and people assigned female at birth can't get prostate cancer, but they can get a similar type, called Skene's gland ...

Pancreatic cancer is difficult to detect but not impossible Certain types of tests although not completely reliable can help ...

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include ...

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

Q2 2025 Earnings Call Transcript July 30, 2025 Pulmonx Corporation beats earnings expectations. Reported EPS is $-0.38, ...